1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Kidney Disease Market – By Product

1.3.2        Kidney Disease Market – By End User

1.3.3        North America Kidney Disease – By Country

2.           North America Kidney Disease – Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Kidney Disease – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Kidney Disease Market- North America PEST Analysis

4.3         Expert Opinion

5.           North America Kidney Disease - Key Market Dynamics

5.1         Market Drivers

5.1.1        Increasing Prevalence of Chronic Kidney Related Diseases

5.1.2        High Growth in Aging Population

5.2         Market Restraints

5.2.1        Failure in Diagnosing Cases of Kidney Disease

5.3         Market Opportunities

5.3.1        A High Rise in Research & Development  Regarding  Kidney Diseases

5.4         Future Trends

5.4.1        Multiple Product Launches and Strategies

5.5         Impact Analysis

6.           Kidney Disease Market – North America Analysis

6.1         North America Kidney Disease Revenue Forecasts and Analysis

7.           North America Kidney Disease Analysis and Forecasts To 2027 – ByProduct

7.1         Overview

7.2         Kidney Disease Market Revenue Share, by Product (2019 and 2027)

7.3         Diagnosis

7.3.1        Overview

7.3.2        Diagnosis: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

7.3.3        Blood Tests

7.3.3.1          Overview

7.3.3.2          Blood Tests: Kidney Disease Market – Revenue and Forecast to 2027(US$ Million)

7.3.4        Urine Tests

7.3.4.1          Overview

7.3.4.2          Urine Tests: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

7.3.5        Imaging Tests

7.3.5.1          Overview

7.3.5.2          Imaging Tests: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

7.3.6        Others

7.3.6.1          Overview

7.3.6.2          Others: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

7.4         Treatment

7.4.1        Overview

7.4.2        Treatment: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

7.4.3        Drug Class

7.4.3.1          Overview

7.4.3.2          Drug Class: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

7.4.3.2.1          ACE Inhibitors

7.4.3.2.1.1       Overview

7.4.3.2.1.2       ACE Inhibitors: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

7.4.3.2.2          Angiotensin-II Receptor Blockers

7.4.3.2.2.1       Overview

7.4.3.2.2.2       Angiotensin-II Receptor Blockers: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

7.4.3.2.3          Diuretics

7.4.3.2.3.1       Overview

7.4.3.2.3.2       Diuretics: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

7.4.3.2.4          Others

7.4.3.2.4.1       Overview

7.4.3.2.4.2       Others: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

7.4.4        Dialysis

7.4.4.1          Overview

7.4.4.2          Dialysis: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

7.4.5        Others

7.4.5.1          Overview

7.4.5.2          Others: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

8.           North America Kidney Disease Analysis – By End-User

8.1         Overview

8.2         Kidney Disease Market Revenue Share, by End User (2019 and 2027)

8.3         Hospitals

8.3.1        Overview

8.3.2        Hospitals: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

8.4         Diagnostic Laboratories

8.4.1        Overview

8.4.2        Diagnostic Laboratories: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

8.5         Others

8.5.1        Overview

8.5.2        Others: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

9.           Kidney Disease Market Revenue and Forecasts To 2027 – Geographical Analysis

9.1         North America: Kidney Disease Market

9.1.1        Overview

9.1.2        North America: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

9.1.3        North America: Kidney Disease Market, by Product – Revenue and Forecast to 2027 (USD Million)

9.1.3.1          North America: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

9.1.3.2          North America: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

9.1.3.2.1          North America: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

9.1.4        North America: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

9.1.5        North America: Kidney Disease Market, by Country, 2019 & 2027 (%)

9.1.6        US: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

9.1.6.1          US: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

9.1.6.2          US: Kidney Disease Market, by Product – Revenue and Forecast to 2027 (USD Million)

9.1.6.2.1          US: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

9.1.6.2.2          US: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

9.1.6.2.2.1       US: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

9.1.6.3          US: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

9.1.7        Canada: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

9.1.7.1          Canada: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

9.1.7.2          Canada: Kidney Disease Market, by Product – Revenue and Forecast to 2027 (USD Million)

9.1.7.2.1          Canada: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

9.1.7.2.2          Canada: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

9.1.7.2.2.1       Canada: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

9.1.7.3          Canada: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

9.1.8        Mexico: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

9.1.8.1          Mexico: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

9.1.8.2          Mexico: Kidney Disease Market, by Product – Revenue and Forecast to 2027 (USD Million)

9.1.8.2.1          Mexico: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

9.1.8.2.2          Mexico: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

9.1.8.2.2.1       Mexico: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

9.1.8.3          Mexico: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.        Impact Of COVID-19 Pandemic on North America Kidney Disease

10.1      North America: Impact Assessment of COVID-19 Pandemic

11.        COMPANY PROFILES

11.1      Abbott

11.1.1     Key Facts

11.1.2     Business Description

11.1.3     Products and Services

11.1.4     Financial Overview

11.1.5     SWOT Analysis

11.1.6     Key Developments

11.2      F. Hoffmann-La Roche Ltd.

11.2.1     Key Facts

11.2.2     Business Description

11.2.3     Products and Services

11.2.4     Financial Overview

11.2.5     SWOT Analysis

11.2.6     Key Developments

11.3      AbbVie Inc.

11.3.1     Key Facts

11.3.2     Business Description

11.3.3     Products and Services

11.3.4     Financial Overview

11.3.5     SWOT Analysis

11.3.6     Key Developments

11.4      Pfizer Inc.

11.4.1     Key Facts

11.4.2     Business Description

11.4.3     Products and Services

11.4.4     Financial Overview

11.4.5     SWOT Analysis

11.4.6     Key Developments

Source: Press Release, Newsletters, and Company Annual Report

12.        Appendix

12.1      About the Insight Partners

12.2      Glossary of terms

Table 1.             North America: Kidney Disease Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 2.             North America: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

Table 3.             North America: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 4.             North America: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 5.             North America: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 6.             US: Kidney Disease Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 7.             US: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

Table 8.             US: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 9.             US: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 10.          US: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 11.          Canada: Kidney Disease Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 12.          Canada: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

Table 13.          Canada: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 14.          Canada: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 15.          Canada: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 16.          Mexico: Kidney Disease Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 17.          Mexico: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

Table 18.          Mexico: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 19.          Mexico: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 20.          Mexico: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 21.          Glossary of Terms,Kidney disease

Figure 1.           Kidney Disease Segmentation

Figure 2.           North America Kidney Disease Overview

Figure 3.           Diagnosis Segment Held Largest Share of Product in Kidney Disease Market

Figure 4.           US is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.           Kidney Disease Market - North America PEST Analysis

Figure 6.           Kidney Disease Market Impact Analysis of Driver and Restraints

Figure 7.           North America Kidney Disease – Revenue Forecasts and Analysis – 2019- 2027

Figure 8.           Kidney Disease Market Revenue Share, by Product (2019 and 2027)

Figure 9.           Diagnosis: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 10.        Blood Tests: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 11.        Urine Tests: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 12.        Imaging Tests: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 13.        Others: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 14.        Treatment: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 15.        Drug Class: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 16.        ACE Inhibitors: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 17.        Angiotensin-II Receptor Blockers: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 18.        Diuretics: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 19.        Others: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 20.        Dialysis: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 21.        Others: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 22.        Kidney Disease Market Revenue Share, by End User (2019 and 2027)

Figure 23.        Hospitals: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 24.        Diagnostic Laboratories: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 25.        Others: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 26.        North America: Kidney Disease Market, by Key Country – Revenue (2019) (USD Million)

Figure 27.        North America: Kidney Disease Market Revenue and Forecast to 2027 (USD Million)

Figure 28.        North America: Kidney Disease Market, by Country, 2019 & 2027 (%)

Figure 29.        US: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

Figure 30.        Canada: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

Figure 31.        Mexico: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

Figure 32.        Impact of COVID-19 Pandemic in North American Country Markets